Mérieux NutriSciences talks about Extractables & Leachables testing Events Mérieux NutriSciences invites you to follow our expert during the 3rd Annual Extractables & Leachables summit 2023....
Nitrosamine impurities, welcome to our dedicated labs Pharmaceuticals Mérieux NutriSciences has a deep experience in nitrosamines analyses in foods, feeds, tobacco, water, cosmetics and phar...
Nitrosamine alerts: EMA never stops updating Q&A documents on nitrosamine impurities Alerts EMA continues updating the document “Questions and answers for marketing authorisation holders/applicants on the CHMP Op...
Behind the scenes with Orianna Marcon Pharmaceuticals We are back in the Mérieux NutriSciences Italia Science Centre, dedicated to complex activities requiring the coordinati...
Behind the scenes with Enrico Ferraro and Margherita Monico Pharmaceuticals We are now in the Science Centre of Mérieux NutriSciences Italia, dedicated to complex activities requiring the coordina...
Behind the scenes with Federica Licitra and Veronica Poletti Services In the Virology and Toxicology Lab we meet two leading professionals, Federica Licitra - Cell biology, Toxicology and Vi...
FREE WEBINAR - Enhancing nitrosamines analysis: A FOCUS ON COMPLEX NITROSAMINES (NDSRIs or NO-APIs) Events FREE WEBINAR Enhancing nitrosamines analysisA FOCUS ON COMPLEX NITROSAMINES (NDSRIs or NO-APIs) Thursday, 6 October 11:0...
Mérieux NutriSciences @CPhIworldwide® 2022 Events The experts of Mérieux NutriSciences Pharma division invite you to deepen the requests of the pharmaceutical industry at...
Scientific writing: vegetal extracts as a replacement for statins to reduce cholesterol Pharmaceuticals Federico Benetti – Executive Director at ECSIN LAB, a Mérieux NutriSciences Company - has been involved in the publicati...
Nitrosamine alerts: on 20 may 2022, EMA updated the Q&A documents on nitrosamine impurities Alerts 20 May 2022 - EMA/409815/2020 Rev.9 EMA has updated the document “Questions and answers for marketing authorisation hold...
Scientific writing: Nanotechnology strategies for the insulin oral delivery Pharmaceuticals Federico Benetti – Executive Director at ECSIN LAB, a Mérieux NutriSciences Company - has been involved in the publicati...
Extractables & Leachables case study - Extractables study on filters for pharmaceutical manufacturing Pharmaceuticals Once again, our expertise goes beyond packaging. Extractables can be obtained not only from the packaging system of the...
Extractables & Leachables case study - Extractables study on silicone tubing used for drug products manufacturing Pharmaceuticals Our expertise goes beyond packaging.Extractables can be obtained not only from the packaging system of the drug product,...
Nitrosamines alert: extended deadline to submit data on NDMA and other impurities in products containing azithromycin Pharmaceuticals Between the end of 2021 and the beginning of 2022, the Competent Authorities has testing on a representative b...
Nitrosamines alerts: recall saga seems to be never ending Alerts Since June 2018, pharmaceutical companies' efforts to identify nitrosamine impurities have not stopped. Patient safety i...
Pharmaceutical packaging: Extractables & Leachables case study - inhalation products Pharmaceuticals Both primary and secondary containers used for drugs must ensure product safety until their expiry date, protect th...
The European Commission banned titanium dioxide as a food additive Regulatory Updates The European Commission banned titanium dioxide as a food additive by publishing Commission Regulation (EU) no. 2022/63...
Nitrosamines alert: Potential for endogenous formation of NDSRIs (nitrosamine drug substance-related impurities) Pharmaceuticals Recently, FDA is pushing to investigate the presence of certain types of nitrosamine impurities - formed in several drug...
Nitrosamine alerts: EMA defined acceptance limit for N-nitrosomorpholine in pharmaceutical products Pharmaceuticals 29 June 2021 - EMA/409815/2020 Rev.4 EMA has updated the document “Questions and answers for marketing authorisation hol...
Nitrosamine alerts: new deadlines for sartans Alerts In November 2020, the CHMP adopted an Opinion concluding that the outcome of the Article 31 referral on angiotensin-II-r...
New presence of nitrosamines in antibacterial drugs based on rifampicin in EU and US Pharmaceuticals New investigations havepermitted to detect the presence of nitrosamine impurities (1-nitroso-4-methyl piperazine, MeNP)...
Nitrosamines alert: update from the European medicines regulatory network Pharmaceuticals The European medicines regulatory network has agreed to extend the deadline to complete step 1 (risk evaluation) as desc...